Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia

Clinical trial NCT00950196 · COMPLETED

Trial details

NCT number: NCT00950196
Sponsor: Sheba Medical Center
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Ataxia Chorea Dystonia Parkinsonism Fatigue

Start date: 2008-11-01
Primary completion: 2009-11-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.